Alnylam Pharmaceuticals reported $575.56M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Amgen AMGN:US $ 5203M 1325M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Avrobio Inc AVRO:US $ 132.41M 29.25M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novartis NVS:US $ 3625M 10227M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Regulus Therapeutics RGLS:US $ 35.12M 18.78M
Sangamo Biosciences SGMO:US $ 117.7M 2.55M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Takeda 4502:JP Y 645991M 203704M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
Xencor XNCR:US $ 49.41M 28.86M
YTE INCY:US $ 2435.38M 178.62M